Get started
Author

Yuangang Su

Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway
2022 · Linhua Wei, Weiwei Chen, et al. · Pharmacological Research · 91
Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
2021 · Yansi Xian, Yuangang Su, et al. · Biochemical Pharmacology · 87
Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis
2023 · Yang Xu, Dezhi Song, et al. · Biomedicine & Pharmacotherapy · 51
Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways
2023 · Yiwu Qin, Dezhi Song, et al. · Biomedicine & Pharmacotherapy · 35
Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways
2020 · Shijie Liao, Wenyu Feng, et al. · Journal of Cellular Physiology · 35
Daphnetin attenuates LPS‐induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways
2019 · Zuoxing Wu, Hailun Wu, et al. · Journal of Cellular Physiology · 33
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
2021 · Xue Yang, Jiamin Liang, et al. · Frontiers in Pharmacology · 31
PDF
Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways
2024 · Kai Gan, Haoyu Lian, et al. · Cell Death Discovery · 27
PDF
The epigallocatechin gallate derivative Y6 reverses drug resistance mediated by the ABCB1 transporter both in vitro and in vivo
2018 · Yan Wen, Ruiqiang Zhao, et al. · Acta Pharmaceutica Sinica B · 26
PDF
Vindoline Inhibits RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss in Mice
2020 · Yunfei Zhan, Jiamin Liang, et al. · Frontiers in Pharmacology · 25
PDF
Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL‐induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation
2023 · Yinglong Xu, Dezhi Song, et al. · Free Radical Biology and Medicine · 24
IKK/NF‐κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS‐induced inflammatory osteolysis
2023 · Xiaoxiao Xie, Weiwei Chen, et al. · Cell Proliferation · 22
PDF
Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption
2020 · Kun Tian, Yuangang Su, et al. · Life Sciences · 20
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis
2023 · Tao Yang, Weiwei Chen, et al. · Journal of Translational Medicine · 17
PDF
AKT/GSK3β/NFATc1 and ROS signal axes are involved in AZD1390-mediated inhibitory effects on osteoclast and OVX-induced osteoporosis
2022 · Shuyue Yang, Dezhi Song, et al. · International Immunopharmacology · 17
Epoxymicheliolide inhibits osteoclastogenesis and resists OVX-induced osteoporosis by suppressing ERK1/2 and NFATc1 signaling
2022 · Feng Long, Runfeng Chen, et al. · International Immunopharmacology · 16
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signaling pathways and ROS
2024 · Jian Huang, Dezhi Song, et al. · Phytotherapy Research · 15
Ethyl caffeate inhibits macrophage polarization via SIRT1/NF-κB to attenuate traumatic heterotopic ossification in mice
2023 · Hui Wang, Dezhi Song, et al. · Biomedicine & Pharmacotherapy · 14
Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
2021 · Xuedong Li, Xixi Lin, et al. · Drug Design Development and Therapy · 14
PDF
Distribution and Regulation of RAB3C, a Small Molecular Weight GTP-Binding Protein
1994 · Y.C. Su, L.S. Kao, et al. · Biochemical and Biophysical Research Communications · 14
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways
2023 · Minglian Xu, Dezhi Song, et al. · iScience · 12
Corilagin attenuates osteoclastic osteolysis by enhancing HO‐1 and inhibiting ROS
2022 · Shaolin Tan, Yuangang Su, et al. · Journal of Biochemical and Molecular Toxicology · 12
Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis
2022 · Linke Huang, Weiwei Chen, et al. · Frontiers in Pharmacology · 11
Rc3h1 negatively regulates osteoclastogenesis by limiting energy metabolism
2024 · Liuyuan Chen, Yuangang Su, et al. · Theranostics · 9
PDF
Hecogenin alleviates LPS-induced osteolysis via regulating pyroptosis and ROS involved Nrf2 activation
2024 · Zhijuan Liu, Yijie Gao, et al. · Biomedicine & Pharmacotherapy · 9
Works count: 50
Citation count: 756
H-index: 16
I10-index: 23
Year
Topic
Type